{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T14:09:35Z","timestamp":1772287775025,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.2169\/internalmedicine.3907-19","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T22:04:39Z","timestamp":1576188279000},"page":"987-990","source":"Crossref","is-referenced-by-count":13,"title":["&lt;i&gt;Pneumocystis jirovecii&lt;\/i&gt; Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy"],"prefix":"10.2169","volume":"59","author":[{"given":"Hirofumi","family":"Watanabe","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurina","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Nihashi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayomi","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuru","family":"Eifuku","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Uto","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Imokawa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Iwata City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 350: 2487-2498, 2004.","DOI":"10.1056\/NEJMra032588"},{"key":"2","unstructured":"2. Tasaka S, Tokuda H, Sakai F, et al. Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study. Intern Med 49: 273-281, 2010."},{"key":"3","unstructured":"3. Kanne JP, Yandow DR, Meyer CA. <i>Pneumocystis jiroveci<\/i> pneumonia: high-resolution CT findings in patients with and without HIV infection. AJR Am J Roentgenol 198: 555-561, 2012."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Salzer HJF, Sch\u00e4fer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with <i>Pneumocystis jirovecii<\/i> pneumonia. Respiration 96: 52-65, 2018.","DOI":"10.1159\/000487713"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Limper AH, Offord KP, Smith TF, Martin II WJ. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140: 1204-1209, 1989.","DOI":"10.1164\/ajrccm\/140.5.1204"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131: 1173-1180, 2007.","DOI":"10.1378\/chest.06-1467"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fillatre P, Decaux O, Jouneau S, et al. Incidence of <i>Pneumocystis jiroveci<\/i> pneumonia among groups at risk in HIV-negative patients. Am J Med 127: 1242.e11-1242.e17, 2014.","DOI":"10.1016\/j.amjmed.2014.07.010"},{"key":"8","unstructured":"8. Yale SH, Limper AH. <i>Pneumocystis carinii<\/i> pneumonia in patients without acquired immunodeficiency syndrome: associated Illnesses and prior corticosteroid therapy. Mayo Clin Proc 71: 5-13, 1996."},{"key":"9","unstructured":"9. Waks AG, Tolaney SM, Galar A, et al. <i>Pneumocystis jiroveci<\/i> pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors. Breast Cancer Res Treat 154: 359-367, 2015."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP. <i>Pneumocystis carinii<\/i> pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol 24: 5330-5331, 2006.","DOI":"10.1200\/JCO.2006.08.1083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Khoo C, Gilchrist J, Williamson JP, Paul M, Kefford R. <i>Pneumocystis jirovecii<\/i> in a patient on dose-dense chemotherapy for early breast cancer. Respirol Case Rep 7: e00459, 2019.","DOI":"10.1002\/rcr2.459"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Inoue N, Fushimi K. Adjunctive corticosteroids decreased the risk of mortality of non-HIV pneumocystis pneumonia. Int J Infect Dis 79: 109-115, 2019.","DOI":"10.1016\/j.ijid.2018.12.001"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV <i>Pneumocystis carinii<\/i> pneumonia. Chest 113: 1215-1224, 1998.","DOI":"10.1378\/chest.113.5.1215"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323: 1500-1504, 1990.","DOI":"10.1056\/NEJM199011223232131"},{"key":"15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1148\/radiographics.20.5.g00se081245","volume":"20","author":"SE Rossi","year":"2000","unstructured":"15. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20: 1245-1259, 2000.","journal-title":"Radiographics","ISSN":"https:\/\/id.crossref.org\/issn\/0271-5333","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/7\/59_3907-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T03:51:33Z","timestamp":1585972293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/7\/59_3907-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3907-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}